Rosenblatt Raises Palantir Price Target to $200
Rosenblatt analyst John McPeake raised the price target on Palantir (NASDAQ: PLTR) to $200.00 (from $150.00) while maintaining a Buy rating.
“War Regrettably Underscores the Value of Palantir Over Just Another LLM–Raising Price Target From $150 to $200 Against Our 2027 Street High Estimates.
On 2/26/26, Anthropic said that their models should not be used in fully autonomous weapons.
The next day (2/27/26), the Trump administration ordered all U.S. agencies to stop using Anthropic’s AI technologies. Then, at 09:45 Tehran time (01:15 ET) on 2/28/26, Operation Epic Fury commenced.
The U.S. government has ordered a six-month phase out period for Anthropic’s LLMs, which we think will leave ample time to switch over to one of the many other LLMs that are supported by Palantir.
We think global instability and the need for comprehensive wartime solutions are likely to lead to deals like the U.S. army deal in July that rolled 75 contracts into just one with Palantir.
We also think that the key LLM performance attribute for theater of war operations is data analysis, and there are indeed adequate alternatives to Anthropic’s Claude in this area.
Our opening target for PLTR was $150 (0.9x PEG off of our Street high 2027 estimates)–over time we think the middle-east conflict is likely to highlight the strength and leverage of Palantir’s solution vs. just another LLM.
We’re taking this opportunity to raise our PEG estimate to 1.2x (88x 2027 EPS), moving our target from $150 to $200.”
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
